Safety and Neuroprotective Efficacy of Palm Oil and Tocotrienol-Rich Fraction from Palm Oil: A Systematic Review

Nutrients. 2020 Feb 18;12(2):521. doi: 10.3390/nu12020521.

Abstract

Background: Several natural products have been reported to elicit beneficial effects against neurodegenerative disorders due to their vitamin E contents. However, the neuroprotective efficacy of palm oil or its tocotrienol-rich fraction (TRF) from the pre-clinical cell and animal studies have not been systematically reviewed.

Methods: The protocol for this systematic review was registered in "PROSPERO" (CRD42019150408). This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The Medical Subject Heading (MeSH) descriptors of PubMed with Boolean operators were used to construct keywords, including ("Palm Oil"[Mesh]) AND "Nervous System"[Mesh], ("Palm Oil"[Mesh]) AND "Neurodegenerative Diseases"[Mesh], ("Palm Oil"[Mesh]) AND "Brain"[Mesh], and ("Palm Oil"[Mesh]) AND "Cognition"[Mesh], to retrieve the pertinent records from PubMed, Scopus, Web of Science and ScienceDirect from 1990 to 2019, while bibliographies, ProQuest and Google Scholar were searched to ensure a comprehensive identification of relevant articles. Two independent investigators were involved at every stage of the systematic review, while discrepancies were resolved through discussion with a third investigator.

Results: All of the 18 included studies in this review (10 animal and eight cell studies) showed that palm oil and TRF enhanced the cognitive performance of healthy animals. In diabetes-induced rats, TRF and α-tocotrienol enhanced cognitive function and exerted antioxidant, anti-apoptotic and anti-inflammatory activities, while in a transgenic Alzheimer's disease (AD) animal model, TRF enhanced the cognitive function and reduced the deposition of β-amyloid by altering the expression of several genes related to AD and neuroprotection. In cell studies, simultaneous treatment with α-tocotrienols and neurotoxins improved the redox status in neuronal cells better than ϒ- and δ-tocotrienols. Both pre-treatment and post-treatment with α-tocotrienol relative to oxidative insults were able to enhance the survival of neuronal cells via increased antioxidant responses.

Conclusions: Palm oil and its TRF enhanced the cognitive functions of healthy animals, while TRF and α-tocotrienol enhanced the cognitive performance with attenuation of oxidative stress, neuroinflammation and apoptosis in diabetes-induced or transgenic AD animal models. In cell studies, TRF and α-tocotrienol exerted prophylactic neuroprotective effects, while α-tocotrienol exerted therapeutic neuroprotective effects that were superior to those of ϒ- and δ-tocotrienol isomers.

Keywords: cognition; neurodegeneration; neuroprotection; palm oil; tocotrienol; tocotrienol-rich fraction.

Publication types

  • Systematic Review

MeSH terms

  • Alzheimer Disease / metabolism
  • Alzheimer Disease / psychology*
  • Alzheimer Disease / therapy
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Anti-Inflammatory Agents
  • Antioxidants
  • Cells, Cultured
  • Chemical Fractionation
  • Cognition / drug effects*
  • Disease Models, Animal
  • Humans
  • Mice
  • Neuroprotective Agents*
  • Oxidative Stress / drug effects*
  • Palm Oil / chemistry
  • Palm Oil / pharmacology*
  • Palm Oil / therapeutic use
  • Phytotherapy
  • Rats
  • Tocotrienols / isolation & purification
  • Tocotrienols / pharmacology*
  • Tocotrienols / therapeutic use

Substances

  • Amyloid beta-Peptides
  • Anti-Inflammatory Agents
  • Antioxidants
  • Neuroprotective Agents
  • Tocotrienols
  • Palm Oil